BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

February 11, 2022 | News

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

The state-of-the-art site marks a significant expansion of the company's advanced protein and gene platforms, and is designed to provide high quality...

February 10, 2022 | News

Nanoform signs GMP manufacturing program with TargTex following formulation success

This follows a successful PoC (Proof of Concept) study where the hydrogel formulation developed by Nanoform (CESS®2 technology-based nanoparticles...

February 07, 2022 | News

Germfree launches novel mobile cleanroom technology for advanced therapies

Germfree’s biomanufacturing platform addresses current industry needs, while de-risking and future-proofing for a rapidly evolving industry. "The ind...

February 03, 2022 | News

CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma

Dr. Michael Quirmbach, Chief Executive Officer & President of CordenPharma said, "We welcome the three sites and their employees as new members to...

February 02, 2022 | News

Debiopharm and Aspen Partner to launch prostate cancer drug trelstar® in South Africa

In 2020, nearly 14,000 South African men were newly diagnosed with prostate cancer1 with an average of 5 men dying from the disease every day.2 I...

February 01, 2022 | News

BeiGene Announces Acceptance of Supplemental New Drug Application in China

BRUKINSA was granted its first breakthrough therapy designation in China with this application The application is supported by SEQUOIA trial results, whic...

January 31, 2022 | News

I-Mab to Accelerate Commercialization of Innovative Biologics Drugs

This strategic partnership will accelerate I-Mab's commercialization strategy with an execution plan and timeline to commercialize its innovative assets, i...

January 31, 2022 | News

HaemaLogiX and Lonza Collaborate to Manufacture KappaMab

Lonza to manufacture drug substance for clinical supply of HaemaLogiX's lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facil...

January 28, 2022 | News

ImmVira's New-Generation Vector Poised to Enable CAR-T Treatment for Solid Tumors

Solid tumor has long been a challenge for CAR-T. Major obstacles include solid tumor heterogeneity, lack of tumor associated antigens as CAR-T targets, com...

January 25, 2022 | News

Partnership with RoosterBio to advance scalable and continuous exosomes manufacturing

Univercells Technologies, a leading provider of novel biomanufacturing technologies for flexible and scalable viral production, announces today a strategic...

January 21, 2022 | News

Sihuan Pharmaceutical Establishment of Joint Venture with Bluepha Co., Ltd

Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as ...

January 21, 2022 | News

The Philippines Has Approved ReCOV For Phase II/III Clinical Trial

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...

January 18, 2022 | News

China Based Gracell Biotechnologies Unveils Innovation Center in U.S.

As a pivotal part of Gracell's global strategy, the company is fully committed to expanding its operations in the U.S. to enhance and diversify its in-hous...

January 13, 2022 | News

Stay Connected